Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus

Osteoarthritis (OA) and type 2 diabetes mellitus (T2D) are two of the most widespread chronic diseases. OA and T2D have common epidemiologic traits, are considered heterogenic multifactorial pathologies that develop through the interaction of genetic and environmental factors, and have common risk f...

Full description

Saved in:
Bibliographic Details
Main Authors: Elena V Tchetina, Galina A Markova, Eugeniya P Sharapova
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Nutrition and Metabolism
Online Access:http://dx.doi.org/10.1155/2020/4143802
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547136068124672
author Elena V Tchetina
Galina A Markova
Eugeniya P Sharapova
author_facet Elena V Tchetina
Galina A Markova
Eugeniya P Sharapova
author_sort Elena V Tchetina
collection DOAJ
description Osteoarthritis (OA) and type 2 diabetes mellitus (T2D) are two of the most widespread chronic diseases. OA and T2D have common epidemiologic traits, are considered heterogenic multifactorial pathologies that develop through the interaction of genetic and environmental factors, and have common risk factors. In addition, both of these diseases often manifest in a single patient. Despite differences in clinical manifestations, both diseases are characterized by disturbances in cellular metabolism and by an insulin-resistant state primarily associated with the production and utilization of energy. However, currently, the primary cause of OA development and progression is not clear. In addition, although OA is manifested as a joint disease, evidence has accumulated that it affects the whole body. As pathological insulin resistance is viewed as a driving force of T2D development, now, we present evidence that the molecular and cellular metabolic disturbances associated with OA are linked to an insulin-resistant state similar to T2D. Moreover, the alterations in cellular energy requirements associated with insulin resistance could affect many metabolic changes in the body that eventually result in pathology and could serve as a unified mechanism that also functions in many metabolic diseases. However, these issues have not been comprehensively described. Therefore, here, we discuss the basic molecular mechanisms underlying the pathological processes associated with the development of insulin resistance; the major inducers, regulators, and metabolic consequences of insulin resistance; and instruments for controlling insulin resistance as a new approach to therapy.
format Article
id doaj-art-2981a69a438749cbaaa4caf92ae5d376
institution Kabale University
issn 2090-0724
2090-0732
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Nutrition and Metabolism
spelling doaj-art-2981a69a438749cbaaa4caf92ae5d3762025-02-03T06:45:46ZengWileyJournal of Nutrition and Metabolism2090-07242090-07322020-01-01202010.1155/2020/41438024143802Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes MellitusElena V Tchetina0Galina A Markova1Eugeniya P Sharapova2Immunology & Molecular Biology Laboratory, Nasonova Research Institute of Rheumatology, Moscow 115522, RussiaImmunology & Molecular Biology Laboratory, Nasonova Research Institute of Rheumatology, Moscow 115522, RussiaOsteoarthritis Laboratory, Nasonova Research Institute of Rheumatology, Moscow 115522, RussiaOsteoarthritis (OA) and type 2 diabetes mellitus (T2D) are two of the most widespread chronic diseases. OA and T2D have common epidemiologic traits, are considered heterogenic multifactorial pathologies that develop through the interaction of genetic and environmental factors, and have common risk factors. In addition, both of these diseases often manifest in a single patient. Despite differences in clinical manifestations, both diseases are characterized by disturbances in cellular metabolism and by an insulin-resistant state primarily associated with the production and utilization of energy. However, currently, the primary cause of OA development and progression is not clear. In addition, although OA is manifested as a joint disease, evidence has accumulated that it affects the whole body. As pathological insulin resistance is viewed as a driving force of T2D development, now, we present evidence that the molecular and cellular metabolic disturbances associated with OA are linked to an insulin-resistant state similar to T2D. Moreover, the alterations in cellular energy requirements associated with insulin resistance could affect many metabolic changes in the body that eventually result in pathology and could serve as a unified mechanism that also functions in many metabolic diseases. However, these issues have not been comprehensively described. Therefore, here, we discuss the basic molecular mechanisms underlying the pathological processes associated with the development of insulin resistance; the major inducers, regulators, and metabolic consequences of insulin resistance; and instruments for controlling insulin resistance as a new approach to therapy.http://dx.doi.org/10.1155/2020/4143802
spellingShingle Elena V Tchetina
Galina A Markova
Eugeniya P Sharapova
Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus
Journal of Nutrition and Metabolism
title Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus
title_full Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus
title_fullStr Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus
title_full_unstemmed Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus
title_short Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus
title_sort insulin resistance in osteoarthritis similar mechanisms to type 2 diabetes mellitus
url http://dx.doi.org/10.1155/2020/4143802
work_keys_str_mv AT elenavtchetina insulinresistanceinosteoarthritissimilarmechanismstotype2diabetesmellitus
AT galinaamarkova insulinresistanceinosteoarthritissimilarmechanismstotype2diabetesmellitus
AT eugeniyapsharapova insulinresistanceinosteoarthritissimilarmechanismstotype2diabetesmellitus